SOPHiA GENETICS
SOPH
SOPH
32 hedge funds and large institutions have $40.1M invested in SOPHiA GENETICS in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$217K | |
| 2 | +$206K | |
| 3 | +$67K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$63K |
| 5 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
+$31.7K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$874K | |
| 3 | -$293K | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$139K |
| 5 |
AA
Alta Advisers
London,
United Kingdom
|
-$110K |